Catalyst Biosciences announces pricing of public offering of common stock
Catalyst Biosciences announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public. The Company granted underwriters an option to purchase up to an additional 441,176 shares of its common stock. February 13, 2018